Riptide Antibiotic Peptide Shows Efficacy in Diabetic Wound Model
January 17, 2023
SAN FRANCISCO, CA. – A designed host defense peptide (dHDP) developed by Riptide Bioscience, Inc., has shown striking efficacy in a murine model of infected diabetic wounds. The research was reported in a peer-reviewed manuscript published in the International Journal of Molecular Sciences.
Professor Dame Carol Black, Internationally-Renowned Physician on Connective Tissue Disorders, joins Riptide Bioscience Advisory Board
April 9, 2020
VALLEJO, CA. – Riptide Bioscience, Inc., today announced that Dame Carol M. Black, FRCP, MACP, FMedSci, Foreign Associate Member of the Institute of Medicine USA, renowned clinician/scientist and eminent expert in systemic sclerosis, has joined the company’s Scientific Advisory Board (SAB).
Riptide Bioscience Announces Discovery of Novel Immune Checkpoint
February 13, 2020
SAN FRANCISCO, CA. – Riptide Bioscience, Inc., announces the publication in Science Translational Medicine of a seminal article establishing a novel immune checkpoint, potentially useful in the treatment of both cancer and fibrosis.
Designed Antimicrobial Peptides for Topical Treatment of Antibiotic Resistant Acne Vulgaris
February 3, 2020
SAN FRANCISCO, CA. – Riptide Bioscience, Inc., announces that key results from the application of its antimicrobial drug candidates for inflammatory acne vulgaris infections have been published in the journal Antibiotics, in an article titled “Designed Antimicrobial Peptides for Topical Treatment of Antibiotic Resistant Acne Vulgaris.”
ASM Journal Article Highlights RP557 Efficacy in Candidiasis
September 1, 2019
SAN FRANCISCO, CA. – Riptide Bioscience, Inc., announces the publication of a research study demonstrating remarkable efficacy for its drug candidate RP557 in recurrent vaginal fungal infections. The study, entitled “Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment,” appears in the August 2019 issue of Antimicrobial Agents and Chemotherapy, a publication of the American Society for Microbiology and the major scholarly journal devoted to antimicrobials (https://aac.asm.org) (doi: 10.1128/AAC.02690-18).
Previous page< Additional articles > Next page